Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo

Oxaliplatin (OXA) is routinely used as the first-line treatment for colorectal cancer (CRC). The addition of OXA to chemotherapy has significantly improved the prognosis of patients with CRC; however, some cases are resistant to OXA. The present study explored the influence of organic cation transpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Juan, Wang, Ling, Li, Tingting, Tang, Shiwei, Wang, Yuhe, Zhang, Wei, Jiang, Xuehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718976/
https://www.ncbi.nlm.nih.gov/pubmed/31524264
http://dx.doi.org/10.3892/or.2019.7267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718976/
https://www.ncbi.nlm.nih.gov/pubmed/31524264
http://dx.doi.org/10.3892/or.2019.7267

Ejemplares similares